DIAGNOS Provides Update on its Health Canada Medical Device Licence Application
Following the submission of its application in early September, DIAGNOS has engaged in ongoing communication with Health Canada, providing timely responses to all regulatory requests. After more than 11 proactive inquiries regarding the application's status, we are pleased to announce that Health Canada has confirmed that the application is now under 'active processing', having progressed from a previous backlog.
"We remain steadfast to complying with all regulatory requirements and ensuring that Health Canada has all the necessary information to support the review of our CARA System application," said André Larente, CEO of Diagnos Inc. "We appreciate the continued collaboration with Health Canada and are optimistic about the future progress of our application."
Diagnos Inc. is dedicated to advancing its mission of providing cutting-edge medical diagnostic solutions, and the CARA System is a key part of the company's growth strategy.
About DIAGNOSDIAGNOS is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems. By leveraging Artificial Intelligence, DIAGNOS aims to provide more information to healthcare clinicians to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes on a global scale.
Additional information is available at www.diagnos.com and www.sedarplus.com.
This news release contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. DIAGNOS disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CONTACT: For further information, please contact: Mr. André Larente, President DIAGNOS Inc. Tel: 450-678-8882 ext. 224 alarente@diagnos.ca
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
How do you know if you have iron deficiency or anemia? We asked an expert about the symptoms to watch for— plus the foods that are high in iron
Our bodies rely on iron from the food we eat. But sometimes, our bodies don't have enough iron stores to keep us feeling our best. Do you ever feel tired, even after a good night's sleep? Or find yourself feeling exhausted after activities you're used to doing? If so, you may be missing a vital mineral in your system: iron. Iron deficiency is common among Canadians, and it's a nutrient deficiency can fly under the radar for an extended period of time. According to the Canadian Digestive Health Foundation, there are many instances where Canadians 'don't recognize the subtle signs of a deficiency until their symptoms have advanced.' Megan Helei Hou, a Canadian clinical dietitian with Aurum Medicine and Wellness Clinic, spoke to Yahoo Canada about what Canadians can do to take care of their iron and their over all health. This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle. What is iron deficiency? Iron deficiency is 'a health condition characterized by low iron stores' with approximately 10.5 per cent of the Canadian population living with the condition at any point in their lives. 'We have iron in our blood; and at the same time it [iron] is stored in our body,' said Hou. 'Our body tries to use its storage first, but if there is no more storage to use then it [iron] will be reflected into our blood cells." According to HealthLink BC, iron deficiency is commonly diagnosed through a complete blood count (CBC), a blood test that can be ordered by a healthcare provider or general practitioner. What are symptoms of iron deficiency? How is it caused? Hou stated that those who live with 'excessive blood loss' are more likely to develop iron deficiency. People with gastrointestinal (GI) bleeding and menstrual bleeding are more susceptible to iron deficiency given the volume of blood that can be lost. Those who have 'low iron absorption' can develop iron deficiency. 'People who have celiac [disease] absorb low amounts of iron, and those people tend to absorb iron less effectively," Hou said. In addition, there are two types of iron, heme and nonheme iron that our bodies are able to absorb, coming from different food sources. With low amounts of either iron, it is possible to develop iron deficiency. 'Heme iron can be found in our blood and comes from animal sources, and nonheme iron means that sources are not from blood, like plant sources,' said Hou. As a result, the most common symptoms of iron deficiency have a high possibility to interrupt one's daily life. 'You start to feel dizziness, your heart rate starts to beat faster, you are more tired than usual,' Hou said. Other symptoms of iron deficiency can include: Headaches Hair loss Impaired immune function Irritability Depression Cold intolerance Restless leg syndrome Nail changes (thin, concave nails) What is the difference between iron depletion, deficiency and anemia? People with low iron can develop different conditions, like iron deficiency, iron depletion and anemia. 'Iron depletion means that the storage in our body has run out, and you don't necessarily feel a lot of the symptoms,' said Hou. 'With iron deficiency, you start to feel the common symptoms. With anemia, there is a lower amount of hypochromic in your body and the red blood cells change." Our bodies need iron to produce hemoglobin, a protein in red blood cells. Red blood cells help carry oxygen to the rest of our body. According to the American Red Cross, approximately 70 per cent of our body's iron is found in hemoglobin. If iron deficiency isn't treated properly, it can impact our production of hemoglobin. This would be a sign that a person's iron stores are so low they are now considered anemic. What are the symptoms of anemia? People with anemia may experience symptoms like: Extreme fatigue Weakness Pale skin Dizziness and/or lightheadedness Craving for ice, dirt Poor appetite Brittle nails Who is at risk for iron deficiency? Women are more likely to develop iron deficiency due to the amount of blood that can be lost during a menstrual cycle, along with women who aer pregnant and breastfeeding. Hou also noted athletes, particularly female athletes, can be high-risk for iron deficiency. 'Athletes in general have higher iron requirements. You lose iron through your sweat, so during exercise you lose iron through that,' she said. 'Teenagers already have higher iron requirements because they are growing, iron is something that is being used when making bodily tissues, so that is already high. Younger female athletes probably first started their menstruation and therefore experience blood loss.' Hou also pointed out that vegetarians and vegans are a 'high risk population' to iron deficiency because they mostly consume foods nonheme iron, which is less "efficiently' stored in our bodies. Foods high in iron Heme sources of iron, which are found in animal-based foods, include: Red meat (beef, lamb, pork) Poultry Liver/kidney meats Seafood Shellfish Non-heme sources of iron for people who want to eat less meat: Nuts Legumes Leafy greens Tofu Beans/soybeans Seeds How can iron deficiency be managed? According to Hou, one of the best ways to alleviate the symptoms of iron deficiency is to undergo a diet change that involves higher intake of iron. It it can take up to six months to feel a difference, so boosting one's iron levels is not just a one-and-done task. 'It's not like you eat a high-iron meal and tomorrow it will all go back to normal, it takes time,' she said. Having your iron levels assessed by a medical professional is key. Your healthcare provider may suggest supplements or further treatment based on the results. Understanding iron supplements There are several different kinds of iron supplements that vary in the amount of elemental iron they provide by weight. Ferrous sulfate: 20 per cent elemental iron Ferrous gluconate: 12 per cent elemental iron Ferric citrate: Approximately 21 per cent elemental iron Ferrous fumarate: 33% elemental iron Ferric sulfate: Approximately 27% elemental iron Although the elemental iron levels may vary by product, it should be readily available on the product's label. Depending on your doctor's recommended dosage, it can take anywhere from one to four weeks to feel better. How to properly take iron supplements It's important to take your iron supplements as prescribed by your healthcare provider. There are some common mistakes that people make which could be impacting the effectiveness of your supplements. Iron supplements should be taken on an empty stomach approximately one to two hours before meals. Similarly, you should avoid drinking milk or caffeine (coffee, tea or cola) for approximately two hours after taking your supplements, since they can impact how your body absorbs iron. Taking your supplements with foods high in vitamin C can help your body absorb iron. Always ask your doctor how iron supplements can interfere with other medications you're taking. For example, iron supplements can prevent the body from absorbing certain medications that treat high blood pressure and osteoporosis. You may need to adjust how and when you're taking your medications. Iron supplement side effects Iron supplements can potentially cause side effects like: Stomachaches (your healthcare provider may recommend taking supplements with food ) Nausea Diarrhea Darkened stool Heartburn
Yahoo
11 hours ago
- Yahoo
TFSA Investors: 2 TSX Stocks With Ultra Safe Dividends
Written by Adam Othman at The Motley Fool Canada Dividend investing is one of the best strategies that Canadian investors rely on for reliable long-term wealth growth. I am not talking about investing in ultra-high-yielding dividend stocks. A sound long-term strategy focuses on sustainability and not higher dividends. Rather than picking stocks for higher yields, it is better to consider whether the underlying business is good enough to maintain and grow payouts. The TSX boasts several high-quality stocks with a reputation for delivering rock-solid dividend payouts and lengthy dividend-growth streaks. These stocks have underlying businesses with solid fundamentals, healthy balance sheets, and the kind of consistent cash flows that make them dependable even during bear markets. Given this backdrop, here are two TSX dividend stocks with ultra-safe dividends that might warrant a place in any self-directed income-focused portfolio. Fortis Fortis Inc. (TSX:FTS) is the darling stock for many income-focused investors as a better alternative to fixed-income securities. The $34.8 billion market-cap company owns and operates 10 utility transmission and distribution assets in Canada and the US, and it has stakes in several utility companies in the Caribbean. Utility companies aren't the most exciting for growth-seeking investors, but they offer reliable dividends. Most of Fortis' revenue comes from long-term contracted assets in highly rate-regulated markets. It means the cash flow is predictable and largely unaffected by broader economic volatility. The debt-intensive nature of the industry means higher interest rates can weigh on its financials. That is what likely contributed to weaker performance in recent years, but the recovery is evident since the central banks started reducing key interest rates. Thanks to its low-risk earnings and the defensive nature of the industry, Fortis stock has increased its payout for 51 years and maintained a sustainable payout ratio. As of this writing, it trades for $69.30 per share and boasts a 3.6% dividend yield. Canadian Natural Resources Canadian Natural Resources Ltd. (TSX:CNQ) is another stock with ultra-safe dividends. The Calgary-headquartered $90.2 billion market-cap company is one of Western Canada's largest oil and natural gas producers, with operations in offshore Africa and the North Sea further supplementing its operations. It has an extensive and diversified portfolio of low-decline and long-life assets. The company's low maintenance capital spending generates significant free cash flows, even when commodity prices are volatile. CNQ also benefits from low break-even costs to sustain dividends and operations, offering it a cushion during downturns and driving growth during upticks. CNQ stock has a 25-year dividend-growth streak, with a 21% compound annual growth rate (CAGR). The company is leveraging the low-interest rate environment to reduce its debt and position itself for potential strategic acquisitions. As of this writing, it trades for $43.12 per share and boasts a 5.5% dividend yield. Foolish takeaway It's important to remember that stock market investing is inherently risky. Dividend hikes or payout regularity are not a 100% guarantee, even when you invest in blue-chip stocks with virtually impeccable track records. By doing your due diligence, you can minimize the capital risk but not eliminate it. Building a portfolio of such high-quality stocks in a Tax-Free Savings Account (TFSA) can be an excellent strategy. The tax-sheltered status of the account means you will not incur income or capital gains taxes on your returns. Reinvesting dividends to buy more shares can help you unlock the power of compounding to accelerate your wealth growth. To this end, FTS stock and CNQ stock can be excellent buy-and-forget holdings to consider for your self-directed investment portfolio. The post TFSA Investors: 2 TSX Stocks With Ultra Safe Dividends appeared first on The Motley Fool Canada. Should you invest $1,000 in Canadian Natural Resources right now? Before you buy stock in Canadian Natural Resources, consider this: The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canadian Natural Resources wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $24,927.94!* Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 30 percentage points since 2013*. See the Top Stocks * Returns as of 6/23/25 More reading 10 Stocks Every Canadian Should Own in 2025 3 Canadian Companies Powering the AI Revolution Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends Canadian Natural Resources and Fortis. The Motley Fool has a disclosure policy. 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
15 hours ago
- Business Wire
LibertyStream Announces Closing of Promissory Note Financing
CALGARY, Alberta--(BUSINESS WIRE)-- LibertyStream Infrastructure Partners Inc. (TSXV: LIB | OTCQB: VLTLF | FSE: I2D) (' LibertyStream ' or the ' Company ') is pleased to announce that it has closed its previously-announced offering of 12% promissory notes (the ' Notes ') for aggregate gross proceeds of $3,530,000 (the ' Offering '). Pathfinder Asset Management Ltd. (' Pathfinder ') purchased $3,400,000 aggregate principal amount of Notes under the Offering, which Notes are senior and secured against all of the Company's present and after-acquired property. The remaining $130,000 aggregate principal amount of the Notes were purchased by Alex Wylie, the Company's President and Chief Executive Officer. The Notes purchased by Mr. Wylie are unsecured The principal balance of each Note will be payable on August 8, 2026 (the ' Maturity Date '), provided that the Company shall have the right to redeem and repay the Notes at any time prior the Maturity Date, in whole or in part, without notice, bonus or penalty. The Notes bear simple interest at a rate of 12% per annum, with interest payable on the Maturity Date. The Company intends to use the proceeds from the Notes to complete the purchase of the refining unit ($2,100,000) (as disclosed in the Company's press release dated July 31, 2025) and for general working capital purposes ($1,430,000) or for such other purposes as the Company may determine to be appropriate in its sole discretion. In connection with the Offering, the Company issued an aggregate of 3,004,255 common shares in the capital of the Company (the ' Bonus Shares ') to Pathfinder and Mr. Wylie. The Bonus Shares represent a value equal to 20% of the principal amount of the Notes, calculated at a price of $0.235 per Bonus Share which was the closing price of the Company's common shares on July 31, 2025 prior to the announcement of the Offering. The Bonus Shares are subject to a four month hold period commencing on August 8, 2025, in accordance with applicable Canadian securities laws and the policies of the Exchange. This news release does not constitute an offer to sell or a solicitation of an offer to sell any securities of the Company in the United States. The Notes and Bonus Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the ' U.S. Securities Act ') or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or except where an exemption from such registration is available. Alex Wylie, the Company's President and Chief Executive Officer, acquired $130,000 aggregate principal amount of Notes and 110,638 Bonus Shares. Accordingly, the Offering constitutes a 'related party transaction' as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (' MI 61-101 '). The Company is relying on the exemptions for the formal valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(b) and 5.7(1)(b) of MI 61-101, as the Notes are not listed, and will not be listed, on a specified market and the fair market value of the Notes and Bonus Shares being issued to the related party does not exceed $2,500,000, as determined in accordance with MI 61-101. The Company has not filed a material change report with respect to the participation of the insiders at least 21 days prior to the closing as the related party participation had not been determined at such time. About LibertyStream Infrastructure Partners LibertyStream is a lithium development and technology company aiming to be one of North America's first commercial producers of lithium carbonates from oilfield brine. Our strategy is to generate value for shareholders by leveraging management's hydrocarbon experience to deploy our proprietary DLE technology directly into existing oil and gas infrastructure, thereby reducing capital costs, lowering risks and supporting the world's clean energy transition. With four differentiating pillars, and a proprietary DLE technology and process, LibertyStream's innovative approach to development is focused on generating the highest lithium recoveries with lowest costs, positioning us for future commercialization. We are committed to operating efficiently and with transparency across all areas of the business staying sharply focused on creating long-term, sustainable shareholder value. Investors and/or other interested parties may sign up for updates about the Company's continued progress on its website: This news release does not constitute an offer to sell or a solicitation of an offer to sell any securities of the Company in the United States. The Notes and Bonus Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the ' U.S. Securities Act ') or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or except where an exemption from such registration is available. Forward Looking Statements This news release includes certain 'forward-looking statements' and 'forward-looking information' within the meaning of applicable Canadian securities laws. When used in this news release, the words 'anticipate', 'believe', 'estimate', 'expect', 'target', 'plan', 'forecast', 'may', 'will', 'would', 'could', 'schedule' and similar words or expressions, identify forward-looking statements or information. Statements, other than statements of historical fact, may constitute forward-looking information and include, without limitation, the use of proceeds of the Offering. With respect to the forward-looking information contained in this press release, the Company has made numerous assumptions. While the Company considers these assumptions to be reasonable, these assumptions are inherently subject to significant uncertainties and contingencies and may prove to be incorrect. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein including the risk of delay in completing the purchase of the Refining Unit, the risk that management's production estimates relating to the Refining Unit turn out to be incorrect, and generally, those known risk factors outlined in the Company's annual information form for the year ended June 30, 2024, the Management's Discussion and Analysis for the six months ended December 31, 2024, and the (final) short form base shelf prospectus dated July 20, 2023. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.